Prospective study of policies and use of therapies for COVID-19 among Australian health services during 2020.

导出 OA

翻译打印收藏纠错

第一作者： Emma L,Smith

第一单位： Monash Infectious Diseases, Monash Health, Melbourne, Victoria, Australia.

作者： Emma L,Smith ^[1] ; Amanda,Gwee ^[2] ; Jason A,Roberts ^[3] ; James S,Molton ^[4] ; Danielle,Wurzel ^[5] ; Carly M,Hughes ^[6] ; Benjamin A,Rogers ^[7]

作者单位： Monash Infectious Diseases, Monash Health, Melbourne, Victoria, Australia. ^[1] Murdoch Children's Research Institute, Melbourne, Victoria, Australia.;Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia. ^[2] University of Queensland Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.;Departments of Pharmacy and Critical Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. ^[3] Western Health, Melbourne, Victoria, Australia. ^[4] Department of Respiratory and Sleep Medicine, The Royal Children's Hospital, Melbourne, Victoria, Australia.;Allergy and Lung Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia. ^[5] Monash Infectious Diseases, Monash Health, Melbourne, Victoria, Australia.;Department of Microbiology, Monash Pathology, Monash Health, Melbourne, Victoria, Australia. ^[6] Monash Infectious Diseases, Monash Health, Melbourne, Victoria, Australia.;Centre for Inflammatory Diseases, Monash University, Melbourne, Victoria, Australia. ^[7]

关键词 Australia COVID-19 SARS-CoV-2 policy therapeutics

主题词澳大利亚(Australia);卫生服务(Health Services);人类(Humans);疾病大流行(Pandemics);政策(Policy);前瞻性研究(Prospective Studies)

DOI 10.1111/imj.15510

PMID 34490712

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交